High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 720-724

  Berglund, Mattias ^a   Hedström, Gustav ^a   Amini, Rose Marie ^b   Enblad, Gunilla ^a   Thunberg, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Diffuse large B cell lymphoma; microRNA 200c; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MICRORNA 200C; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GENE EXPRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICRORNAS; MIDDLE AGED; PREDNISONE; VINCRISTINE; YOUNG ADULT;

EID: 84872793339     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2173     Document Type: Article

References (28)

1. Habermann TM, Weller EA, Morrison VA, et al: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24: 3121-3127, 2006. (Pubitemid 46638950)
2. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000. (Pubitemid 30082188)
3. Rosenwald A, Wright G, Chan WC, et al: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346: 1937-1947, 2002. (Pubitemid 34651353)
4. Ninan MJ, Wadhwa PD and Gupta P: Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 52: 360-373, 2011.
5. Kim VN, Han J and Siomi MC: Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139, 2009.
6. Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524, 2006. (Pubitemid 43345317)
7. Davis BN and Hata A: microRNA in cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 1: 1100-1114, 2010.
8. Hobert O: Common logic of transcription factor and microRNA action. Trends Biochem Sci 29: 462-468, 2004. (Pubitemid 39158869)
9. Alencar AJ, Malumbres R, Kozloski GA, et al: MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res 17: 4125 - 41352011.
10. Calin GA, Ferracin M, Cimmino A, et al: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005. (Pubitemid 41549891)
11. Marcucci G, Radmacher MD, Maharry K, et al: MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1919-1928, 2008. (Pubitemid 351620112)
12. Montes-Moreno S, Martinez N, Sanchez-Espiridion B, et al: miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood 118: 1034-1040, 2011.
13. Schwind S, Maharry K, Radmacher MD, et al: Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 28: 5257-5264, 2010.
14. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
15. Chang CJ, Chao CH, Xia W, et al: p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317-323, 2011.
16. Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283: 14910-14914, 2008.
17. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
18. Papadopoulou V, Postigo A, Sanchez-Tillo E, Porter AC and Wagner SD: ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus. Biochem J 427: 541-550, 2010.
19. Lossos IS, Jones CD, Warnke R, et al: Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 98: 945-951, 2001.
20. Shimono Y, Zabala M, Cho RW, et al: Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592-603, 2009.
21. Wellner U, Schubert J, Burk UC, et al: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495, 2009.
22. Korpal M, Ell BJ, Buffa FM, et al: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17: 1101-1108, 2011.
23. Hamano R, Miyata H, Yamasaki M, et al: Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 17: 3029-3038, 2011.
24. Liu LZ, Zhou XD, Qian G, Shi X, Fang J and Jiang BH: AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway. Cancer Res 67: 6325-6332, 2007. (Pubitemid 47037515)
25. Thompson JE and Thompson CB: Putting the rap on Akt. J Clin Oncol 22: 4217-4226, 2004. (Pubitemid 41185193)
26. Uddin S, Hussain AR, Siraj AK, et al: Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178-4186, 2006. (Pubitemid 44913290)
27. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
28. Hans CP, Weisenburger DD, Greiner TC, et al: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282, 2004. (Pubitemid 38029949)